# Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma

> **NCT01863108** · PHASE1 · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 9 (actual)

## Conditions studied

- Melanoma
- Tumor Vaccines
- Effects of Immunotherapy

## Interventions

- **BIOLOGICAL:** GeniusVac-Mel4

## Key facts

- **NCT ID:** NCT01863108
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2017-03-23
- **Final completion:** 2017-03-23
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-08-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01863108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01863108, "Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01863108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*